查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617082

到 2030 年过敏性结膜炎市场预测：按类型、年龄层、药物类型、药物类别、剂型、分销管道、最终用户和地区进行的全球分析

Allergic Conjunctivitis Market Forecasts to 2030 - Global Analysis By Type, Age Group, Drug Type, Drug Class, Formulation, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球过敏性结膜炎市场规模将达到 32 亿美元，预计 2030 年将达到 46 亿美元，预测期内复合年增长率为 6.3%。

过敏性结膜炎是一种眼睛炎症，由对花粉、尘螨、宠物皮屑或霉菌等物质的过敏反应引起。它通常会影响双眼，症状包括发红、发痒、水样分泌物和肿胀。这种情况是由于接触过敏原后结膜（覆盖眼白的膜）中的组织胺被活化引起的。

根据 NLM 的一篇报导，过敏性眼科疾病影响着北美约 40% 的人口。

眼睛过敏增加

过敏性眼科疾病（尤其是结膜炎）的增加增加了对治疗解决方案的需求。病例数的增加与污染、过敏原和气候变迁等环境因素有关，促使医疗专业人员专注于有效的治疗方法。随着越来越多的人寻求缓解症状，大众对过敏性结膜炎的认识不断提高也有助于市场扩张。

治疗费用高

过敏性结膜炎的药物治疗、诊断测试和长期治疗等治疗费用高昂，是市场的主要限制因素。对许多患者来说，负担得起的治疗很困难，特别是在中低收入地区，限制了市场的成长潜力。此外，医疗保健差距和保险覆盖范围不足也加剧了经济问题。

网路药局成长

电子商务的兴起，特别是在线药房的扩张，正在为过敏性结膜炎市场创造巨大的成长机会。患者现在可以透过这些平台轻鬆获得处方药和非处方治疗。便利性、有竞争力的价格和送货上门的选择可能有助于提高产品的可及性并推动市场成长。

与学名药的竞争

学名药供应量的增加对过敏性结膜炎市场上的品牌产品构成了威胁。学名药以较低的价格提供相同的功效，越来越受欢迎，尤其是在价格敏感的市场。这种变化正在威胁创新药物开发商的市场占有率，迫使他们采取新的策略，例如付加产品差异化和改善患者治疗结果。

COVID-19 的影响：

COVID-19 大流行扰乱了全球医疗保健系统，并影响了过敏性结膜炎的诊断和治疗。社交距离措施、关门以及将医疗资源转移到 COVID-19 上，加剧了眼睛过敏管理的挑战。然而，对医疗保健的日益关注和数位医疗保健平台的更多使用减轻了其中一些影响，并促进了持续获得治疗。

预计季节性过敏性结膜炎在预测期内将是最大的部分

在预测期内，季节性过敏性结膜炎预计仍将是最大的市场区隔。此病在某些季节流行，特别是在花粉数量增加的春季和秋季。因此，更多的患者在这段时间寻求治疗，增加了对抗组织胺和减充血剂等治疗方案的需求，推动了该行业的成长。

预测期内，眼科诊所产业预计复合年增长率最高

在估计和预测期内，预计眼科诊所行业的年平均增长率最高。这些诊所提供的专业服务以及先进的诊断技术和针对过敏性结膜炎的标靶治疗越来越受欢迎。人们对眼睛健康的认识不断提高，导致更多患者寻求专门治疗，从而促进了该细分市场的成长。

比最大的地区

预计在预测期内，北美将主导过敏性结膜炎市场占有率。该地区先进的医疗基础设施、高度的认知度以及多种治疗选择的可用性是推动市场成长的关键因素。此外，北美过敏性疾病的日益普及也增加了对结膜炎治疗的需求。

复合年增长率最高的地区：

预计亚太地区在预测期内过敏性结膜炎市场的复合年增长率最高。这一增长归因于印度和中国等新兴国家过敏性疾病盛行率的上升、都市化的提高以及医疗保健服务范围的扩大。此外，不断增长的中产阶级人口和不断变化的生活方式进一步推动了该地区对过敏治疗的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球过敏性结膜炎市场：按类型

  • 季节性过敏性结膜炎
  • 常年性过敏性结膜炎
  • 巨乳头性结膜炎
  • 春卡他
  • 特应性角结膜炎

第六章全球过敏性结膜炎市场：依年龄组

  • 儿童（18岁以下）
  • 成人（18岁以上）

第七章全球过敏性结膜炎市场：依药物类型

  • 处方药
  • 非处方药 (OTC)

第八章全球过敏性结膜炎市场：依药物类别

  • 抗组织胺和肥大细胞稳定剂
  • 皮质类固醇
  • 免疫调节剂
  • NSAIDs
  • 人工泪液和润滑剂

第九章全球过敏性结膜炎市场：按剂型

  • 眼药水
  • 眼药膏
  • 口腔医学

第10章全球过敏性结膜炎市场：按分销管道

  • 医院药房
  • 零售药房
  • 网路药房

第十一章全球过敏性结膜炎市场：依最终用户分类

  • 眼科诊所
  • 医院
  • 门诊手术中心

第十二章全球过敏性结膜炎市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十三章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十四章 公司概况

  • Alcon
  • Allergan
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharma Advanced Research Company
  • Laboratoires Thea
  • Aciex Therapeutics
  • Sirion Therapeutics
  • Boehringer Ingelheim
  • Atopix Therapeutics
  • Laila Pharmaceuticals
  • Regeneron Pharmaceuticals, Inc.
  • Auven Therapeutics
  • Johnson & Johnson Vision
  • Sanofi
  • Zhaoke Ophthalmology Limited
  • Oyster Point Pharma
Product Code: SMRC27960

According to Stratistics MRC, the Global Allergic Conjunctivitis Market is accounted for $3.2 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Allergic conjunctivitis is an inflammation of the eyes resulting from an allergic reaction to substances like pollen, dust mites, pet dander, or mold. It usually affects both eyes and has symptoms like redness, itching, watery discharge, and swelling. The condition results from the activation of histamines in the conjunctiva, which is the membrane covering the white part of the eyes, upon exposure to allergens.

According to an article in NLM, in North America, approximately 40% of the population is affected by allergic eye disease.

Market Dynamics:

Driver:

Increasing prevalence of eye allergies

The growing number of allergic eye conditions, particularly conjunctivitis, is driving demand for treatment solutions. The rising cases are linked to environmental factors like pollution, allergens, and climate change, prompting healthcare professionals to focus on effective therapies. The increasing awareness of allergic conjunctivitis among the population is also contributing to the market's expansion as more individuals seek relief from symptoms.

Restraint:

High treatment costs

The high cost of treatments, including medications, diagnostic tests, and long-term management of allergic conjunctivitis, is a significant restraint in the market. Many patients find it challenging to access affordable care, especially in low- and middle-income regions, which limits the growth potential of the market. Additionally, healthcare disparities and inadequate insurance coverage also exacerbate the affordability challenge.

Opportunity:

Growth of online pharmacies

The rise of e-commerce, particularly the expansion of online pharmacies, presents significant growth opportunities for the allergic conjunctivitis market. Patients now have easier access to prescribed medications and over-the-counter treatments through these platforms. The convenience, competitive pricing, and doorstep delivery options contribute to increased product accessibility, which could fuel market growth.

Threat:

Competition from generic drugs

The growing availability of generic alternatives poses a threat to branded products in the allergic conjunctivitis market. Generic drugs, offering the same efficacy at lower prices, are gaining popularity, especially in price-sensitive markets. This shift threatens the market share of innovative drug developers, forcing them to adopt new strategies such as differentiating their products with added value or improving patient outcomes.

Covid-19 Impact:

The COVID-19 pandemic disrupted healthcare systems globally, impacting the diagnosis and treatment of allergic conjunctivitis. Social distancing measures, lockdowns, and the redirection of healthcare resources towards COVID-19 exacerbated the challenges in managing eye allergies. However, the increased focus on hygiene and the growing use of digital healthcare platforms helped mitigate some of these impacts, facilitating continued treatment access.

The seasonal allergic conjunctivitis segment is expected to be the largest during the forecast period

Over the estimation period, the seasonal allergic conjunctivitis segment is expected to remain the largest segment. This condition is more prevalent during specific seasons, particularly spring and autumn when pollen levels rise. As a result, a higher number of patients seek medical attention during these periods, driving demand for treatment options like antihistamines and decongestants, boosting the segment growth.

The ophthalmology clinics segment is expected to have the highest CAGR during the forecast period

Over the estimation period, the ophthalmology clinics segment is expected to experience the highest compound annual growth rate during the forecast period. The specialized services offered by these clinics, along with advanced diagnostic techniques and targeted therapies for allergic conjunctivitis, make them increasingly popular. As awareness of eye health increases, more patients are seeking specialized care, contributing to the growth of this segment.

Region with largest share:

North America is anticipated to dominate the allergic conjunctivitis market share during the forecast period. The region's advanced healthcare infrastructure, high awareness levels, and the availability of a wide range of treatment options are key factors driving market growth. Additionally, the increasing prevalence of allergic diseases in North America contributes to the demand for conjunctivitis treatments.

Region with highest CAGR:

The Asia Pacific region is projected to register the highest CAGR in the allergic conjunctivitis market during the forecast period. This growth is attributed to the rising incidence of allergic diseases, increasing urbanization, and the expansion of healthcare access in developing countries like India and China. Additionally, the growing middle-class population and changing lifestyle factors further fuel the demand for allergy treatments in this region.

Key players in the market

Some of the key players in Allergic Conjunctivitis Market include Alcon, Allergan, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co., Ltd., Sun Pharma Advanced Research Company, Laboratoires Thea, Aciex Therapeutics, Sirion Therapeutics, Boehringer Ingelheim, Atopix Therapeutics, Laila Pharmaceuticals, Regeneron Pharmaceuticals, Inc., Auven Therapeutics, Johnson & Johnson Vision, Sanofi, Zhaoke Ophthalmology Limited, and Oyster Point Pharma.

Key Developments:

In March 2024, Santen Pharmaceutical Co., Ltd. (hereinafter Santen) has announced that it successfully obtained manufacturing and marketing approval, for a new long-acting, trans-eyelid formulation for treating allergic conjunctivitis, "Alesion(R) eyelid cream 0.5%" (generic name: epinastine hydrochloride, development code: STN1011402). Alesion(R) eyelid cream 0.5% is a cream-type formulation to be applied to the periocular area (upper and lower eyelids) once a day. It is the world's first cream-format treatment for allergic conjunctivitis.

In February 2021, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Pataday(R) Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (OTC).

Types Covered:

  • Seasonal Allergic Conjunctivitis
  • Perennial Allergic Conjunctivitis
  • Giant Papillary Conjunctivitis
  • Vernal Keratoconjunctivitis
  • Atopic Keratoconjunctivitis

Age Groups Covered:

  • Pediatric (Below 18 years)
  • Adult (18 years and above)

Drug Types Covered:

  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs

Drug Classes Covered:

  • Antihistamine & Mast Cell Stabilizers
  • Corticosteroids
  • Immunomodulators
  • NSAIDs
  • Artificial Tears & Lubricants

Formulations Covered:

  • Eye Drops
  • Eye Ointments
  • Oral Medications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End Users Covered:

  • Ophthalmology Clinics
  • Hospitals
  • Ambulatory Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Allergic Conjunctivitis Market, By Type

  • 5.1 Introduction
  • 5.2 Seasonal Allergic Conjunctivitis
  • 5.3 Perennial Allergic Conjunctivitis
  • 5.4 Giant Papillary Conjunctivitis
  • 5.5 Vernal Keratoconjunctivitis
  • 5.6 Atopic Keratoconjunctivitis

6 Global Allergic Conjunctivitis Market, By Age Group

  • 6.1 Introduction
  • 6.2 Pediatric (Below 18 years)
  • 6.3 Adult (18 years and above)

7 Global Allergic Conjunctivitis Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription Drugs
  • 7.3 Over-the-Counter (OTC) Drugs

8 Global Allergic Conjunctivitis Market, By Drug Class

  • 8.1 Introduction
  • 8.2 Antihistamine & Mast Cell Stabilizers
  • 8.3 Corticosteroids
  • 8.4 Immunomodulators
  • 8.5 NSAIDs
  • 8.6 Artificial Tears & Lubricants

9 Global Allergic Conjunctivitis Market, By Formulation

  • 9.1 Introduction
  • 9.2 Eye Drops
  • 9.3 Eye Ointments
  • 9.4 Oral Medications

10 Global Allergic Conjunctivitis Market, By Distribution Channel

  • 10.1 Introduction
  • 10.2 Hospital Pharmacies
  • 10.3 Retail Pharmacies
  • 10.4 Online Pharmacies

11 Global Allergic Conjunctivitis Market, By End User

  • 11.1 Introduction
  • 11.2 Ophthalmology Clinics
  • 11.3 Hospitals
  • 11.4 Ambulatory Surgical Centers

12 Global Allergic Conjunctivitis Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Alcon
  • 14.2 Allergan
  • 14.3 Bausch Health Companies Inc.
  • 14.4 Novartis AG
  • 14.5 Santen Pharmaceutical Co., Ltd.
  • 14.6 Sun Pharma Advanced Research Company
  • 14.7 Laboratoires Thea
  • 14.8 Aciex Therapeutics
  • 14.9 Sirion Therapeutics
  • 14.10 Boehringer Ingelheim
  • 14.11 Atopix Therapeutics
  • 14.12 Laila Pharmaceuticals
  • 14.13 Regeneron Pharmaceuticals, Inc.
  • 14.14 Auven Therapeutics
  • 14.15 Johnson & Johnson Vision
  • 14.16 Sanofi
  • 14.17 Zhaoke Ophthalmology Limited
  • 14.18 Oyster Point Pharma

List of Tables

  • Table 1 Global Allergic Conjunctivitis Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Allergic Conjunctivitis Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Allergic Conjunctivitis Market Outlook, By Seasonal Allergic Conjunctivitis (2022-2030) ($MN)
  • Table 4 Global Allergic Conjunctivitis Market Outlook, By Perennial Allergic Conjunctivitis (2022-2030) ($MN)
  • Table 5 Global Allergic Conjunctivitis Market Outlook, By Giant Papillary Conjunctivitis (2022-2030) ($MN)
  • Table 6 Global Allergic Conjunctivitis Market Outlook, By Vernal Keratoconjunctivitis (2022-2030) ($MN)
  • Table 7 Global Allergic Conjunctivitis Market Outlook, By Atopic Keratoconjunctivitis (2022-2030) ($MN)
  • Table 8 Global Allergic Conjunctivitis Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 9 Global Allergic Conjunctivitis Market Outlook, By Pediatric (Below 18 years) (2022-2030) ($MN)
  • Table 10 Global Allergic Conjunctivitis Market Outlook, By Adult (18 years and above) (2022-2030) ($MN)
  • Table 11 Global Allergic Conjunctivitis Market Outlook, By Drug Type (2022-2030) ($MN)
  • Table 12 Global Allergic Conjunctivitis Market Outlook, By Prescription Drugs (2022-2030) ($MN)
  • Table 13 Global Allergic Conjunctivitis Market Outlook, By Over-the-Counter (OTC) Drugs (2022-2030) ($MN)
  • Table 14 Global Allergic Conjunctivitis Market Outlook, By Drug Class (2022-2030) ($MN)
  • Table 15 Global Allergic Conjunctivitis Market Outlook, By Antihistamine & Mast Cell Stabilizers (2022-2030) ($MN)
  • Table 16 Global Allergic Conjunctivitis Market Outlook, By Corticosteroids (2022-2030) ($MN)
  • Table 17 Global Allergic Conjunctivitis Market Outlook, By Immunomodulators (2022-2030) ($MN)
  • Table 18 Global Allergic Conjunctivitis Market Outlook, By NSAIDs (2022-2030) ($MN)
  • Table 19 Global Allergic Conjunctivitis Market Outlook, By Artificial Tears & Lubricants (2022-2030) ($MN)
  • Table 20 Global Allergic Conjunctivitis Market Outlook, By Formulation (2022-2030) ($MN)
  • Table 21 Global Allergic Conjunctivitis Market Outlook, By Eye Drops (2022-2030) ($MN)
  • Table 22 Global Allergic Conjunctivitis Market Outlook, By Eye Ointments (2022-2030) ($MN)
  • Table 23 Global Allergic Conjunctivitis Market Outlook, By Oral Medications (2022-2030) ($MN)
  • Table 24 Global Allergic Conjunctivitis Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 25 Global Allergic Conjunctivitis Market Outlook, By Hospital Pharmacies (2022-2030) ($MN)
  • Table 26 Global Allergic Conjunctivitis Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 27 Global Allergic Conjunctivitis Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 28 Global Allergic Conjunctivitis Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Allergic Conjunctivitis Market Outlook, By Ophthalmology Clinics (2022-2030) ($MN)
  • Table 30 Global Allergic Conjunctivitis Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 31 Global Allergic Conjunctivitis Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.